<DOC>
	<DOCNO>NCT02321800</DOCNO>
	<brief_summary>To determine efficacy safety intravenous S-649266 hospitalize adult complicate urinary tract infection cause Gram-negative pathogen .</brief_summary>
	<brief_title>A Study Efficacy/Safety Intravenous S-649266 Versus Imipenem/Cilastatin Complicated Urinary Tract Infections</brief_title>
	<detailed_description>The purpose study determine efficacy safety intravenous S 649266 versus intravenous imipenem/cilastatin hospitalize adult complicate urinary tract infection without pyelonephritis acute uncomplicated pyelonephritis cause Gram-negative pathogen .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Urinary Tract Infections</mesh_term>
	<mesh_term>Pyelonephritis</mesh_term>
	<mesh_term>Imipenem</mesh_term>
	<mesh_term>Cilastatin</mesh_term>
	<criteria>Hospitalized male female patient ≥ 18 year Clinical diagnosis either complicate urinary tract infection ( cUTI ) without pyelonephritis acute uncomplicated pyelonephritis cUTI diagnose history ≥ 1 following : indwelling urinary catheter recent instrumentation urinary tract , Urinary retention ( cause benign prostatic hypertrophy ) , urinary retention least 100 mL residual urine voiding ( neurogenic bladder ) , obstructive uropathy , azotemia cause intrinsic renal disease ( blood urea nitrogen creatinine value great normal laboratory value ) At least 2 follow sign symptom : chill rigor warmth associate fever ( temperature great equal 38 degree Celsius ) , flank pain ( pyelonephritis ) suprapubic/pelvic pain ( cUTI ) , nausea vomiting , dysuria , urinary frequency , urinary urgency , costovertebral angle tenderness physical examination Urinalysis evidence pyuria demonstrate dipstick analysis positive leukocyte esterase ≥10 white blood cell ( WBCs ) per μL unspun urine , ≥ 10 WBCs per high power field spin urine Positive urine culture within 48 hour prior randomization contain ≥10^5 colony form unit ( CFU ) /mL Gramnegative uropathogen likely susceptible imipenem ( IPM ) Patients treated effective antibiotic 24 hour previous 72 hour Patients fail treatment , clinically microbiologically , identify uropathogen nonsusceptible empiric treatment Gramnegative uropathogen likely susceptible IPM Subjects receive antibiotic prophylaxis UTI present sign symptom consistent active new UTI Urine culture identifies Grampositive pathogen and/or Gramnegative uropathogen resistant IPM Urine culture study entry isolate 2 uropathogens patient confirm fungal UTI Asymptomatic bacteriuria , presence &gt; 10^5 CFU/mL uropathogen pyuria without local systemic symptom Patient receive hemodialysis peritoneal dialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>S-649266</keyword>
	<keyword>complicate urinary tract infection</keyword>
	<keyword>cefiderocol</keyword>
	<keyword>acute uncomplicated pyelonephritis</keyword>
	<keyword>Gram-negative pathogen</keyword>
	<keyword>imipenem/cilastatin</keyword>
</DOC>